1Sackett DL, Strans SE, Richardson WS, et al. Evidence-based medicine: how to practice and teach EBM[ M]. 2nd ed. London:Churchill Livingstone, 2000.173-177.
2Dodd JM, Crowther CA, Dare MR, et al. Oral betamimetics for maintenance therapy after threatened preterm labour. Coch Datab of Syst Rev 2006, Issue 1. Art. No. : CD003927. DOI: 10. 1002/14651858. CD003927. pub2.
3Yamasmit W, Chaithongwongwatthana S, Tolosa JE, et al. Prophylactic oral betamimetics for reducing preterm birth in women with a twill pregnancy. Coch Data of Syst Rev 2005, Issue 3. Art. No. : CD004733. DOI: 10. 1002/ 14651858. CD004733. pub2.
4Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Coch Data of Syste Rev 2002, Issue 4. Art. No.: CD001060. DOI: 10. 1002/14651858. CD001060
5King J, Flenady V, Cole S, et al. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Coch Data of Syst Rev 2005, Issue 2. Art. No. : CD001992. DOI: 10. 1002/ 14651858. CD001992. pub2
6King JF, Flenady VJ, Papatsonis DNM, et al. Calcium channel blockers for inhibiting preterm labour. Coch Data of Syste Rev 2003, Issue 1. Art. No. : CD002255. DOI: 10. 1002/ 14651858. CD002255.
7Papatsonis D, Flenady V, Cole S, et al. Oxytocin receptor antagonists for inhibiting preterm labour. Coch Data of Syste Rev 2005, Issue 3. Art. No. : 14651858. CD004452. pub2.
8Dodd JM, Flenady V, Cincotta R, et al. Prenatal administration of progesterone for preventing preterm birth. Coch Data of Syste Rev 2006, Issue 1. Art. No. : CD004947. DOI: 10.1002/ 14651858. CD004947. pub2.
9Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Coch Data of Syste Rev 2006, Issue 3. Art. No. : CD004454. DOI: 10. 1002/14651858. CD004454. pub2.
10Crowther CA, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Coch Data of Syste Rev 2007, Issue 3. Art. No. : CD003935. DOI: 10. 1002/ 14651858. CD003935. pub2.
3Mangesi L, Hofmeyr GJ. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database Syst Rev, 2007, (1) :CD004909.
4Liston R, Sawchuck D, Young D. Fetal health surveillance: antepartum and intrapartum consensus guideline. J Obstet Gynaecol Can, 2007, 29:S3-S56.
5Macones GA, Hankins GD, Spong CY, et ak The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. Obstet Gynecol, 2008, 112:661-666.
6American College of Obstetricians and Gynecologists. AGOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. Obstet Gynecol, 2009, 114:192-202.
7Neilson JP, Alfirevic Z. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev, 2000, (2) :CD000073.
8PiazzeJ, Gioia S, Cerekja A, et al. Doppler velocimetry alterations related to platelet changes in third trimester pregnancies. Platelets, 2007, 18:11-15.
9East CE, Gascoigne MB, Doran CM, et al. A costeffectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial). BJOG, 2006, 113:1080-1087.
10Klauser CK, Christensen EE, Chauhan SP, et al. Use of fetal pulse oximetry among high-risk women in labor: a randomized clinical trial. Am J Obstet Gynecol, 2005, 192: 1810-1817.
